Showing results (171-180 of 268) with videos related to
Sort By:
Pageof 27
Seminars in Oncology|February 1, 1991
Intraperitoneal cisplatin-based chemotherapy for ovarian carcinomaS B Howell, S Kirmani, E F McClay, et al.Cancer Research|May 15, 1994
Cellular pharmacology of dichloro(ethylenediamine)platinum(II) in cisplatin-sensitive and resistant human ovarian carcinoma cellsA P Jekunen, D K Hom, J E Alcaraz, et al.Journal of the National Cancer Institute|October 23, 1997
Loss of DNA mismatch repair: effects on the rate of mutation to drug resistanceM M de las Alas, S Aebi, D Fink, et al.The New England Journal of Medicine|April 11, 1985
A comparison of the treatment of rheumatoid arthritis in health maintenance organizations and fee-for-service practicesE H Yelin, C J Henke, J S Kramer, et al.Annals of Internal Medicine|June 1, 1982
The information content from renal biopsy in systemic lupus erythematosusQ Whiting-O'Keefe, J E Henke, M A Shearn, et al.The Journal of Clinical Investigation|July 1, 1976
Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseasesJ L Feldmann, M J Becker, H Moutsopoulos, et al.Annals of Internal Medicine|June 1, 1982
Recognition of information in renal biopsies of patients with lupus nephritisQ Whiting-O'Keefe, P J Riccardi, J E Henke, et al.Cancer Research|April 1, 1993
Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cellsE F McClay, K D Albright, J A Jones, et al.Surgical Oncology|January 1, 1993
Regional lymphatic drug exposure following intraperitoneal administration of 5-fluorouracil, carboplatin, and etoposideP Lindnér, D D Heath, D R Shalinsky, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Effect of topoisomerase modulators on cisplatin cytotoxicity in human ovarian carcinoma cellsE J Katz, J S Vick, K M Kling, et al.Pageof 27